ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
HLA typing and sequencing at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
58 organizations at ASHI 2026 present work in HLA typing, sequencing and genotyping, led by hospitals, blood centers and donor organizations. Between them they bring 165 presentations to the program. Most represented: University of California, Los Angeles, University of British Columbia and Thermo Fisher Scientific. As of Oct 25, 2026.
| Organization | ASHI 2026 Attendance |
|---|---|
University of California, Los Angeles Los Angeles, CA | |
Public research university with a medical school and health system, home to the UCLA Immunogenetics Center for HLA and transplant testing. | Session Tue Oct 27 10:15am–11:45am Plenary 1: Alloimmune Responses after Solid Organ Transplantation: From immunopeptidome and viral mimicry to non-HLA genomics Solid organ transplantationHLA typing, sequencing and genotyping Industry Tue Oct 27 12:30pm–1:25pm Redefining Histocompatibility: Faster HLA Typing, Deeper Ab Insights HLA typing, sequencing and genotypingHLA antibodies, crossmatching and eplets Talk Tue Oct 27 2:45pm–3:00pm Sensitization in Transplantation: Assessment of Risk (STAR)- Analytical Validity of the Two Luminex Assays for Non-HLA Antibody Detection Demonstrates Reproducibility Within Vendors but Discordance Between Vendors HLA antibodies, crossmatching and epletsLab quality, accreditation and operations Session Thu Oct 29 1:10pm–2:40pm Abstract IV: Rethinking the Bench: Innovation, Validation, and Bias Elimination in Transplant Diagnostics Lab quality, accreditation and operations Talk Thu Oct 29 1:40pm–1:55pm CD33-Based Myeloid Cell Isolation May Introduce Systematic Bias in Lineage-Specific Chimerism Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Talk Thu Oct 29 1:55pm–2:10pm Assessment and Standardization of a Single Antigen Bead Assay for the Detection of Non-HLA Antibodies HLA antibodies, crossmatching and epletsLab quality, accreditation and operations Talk Thu Oct 29 2:25pm–2:40pm Reperfusion Endotypes are Associated with Monocyte PD-L1 Suppression, Tfh-driven De Novo HLA Class II DSA, and Graft Outcomes in Orthotopic Liver Transplantation Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Non-HLA Antibodies Define an Endothelial-Reactive Axis of Antibody-Mediated Rejection Independent of HLA-DSA HLA antibodies, crossmatching and epletsSolid organ transplantation Poster Identification of HLA-B*14:02 Somatic Mutation in Patient evaluated for Hematopoietic Stem Cell Transplantation HLA typing, sequencing and genotypingStem cell transplantation and cell therapy Poster Efficacy of Desensitization in Lung Transplant Recipients with Preformed Donor Specific Antibodies Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Low-Level Chimerism Discordance Between STR and NGS Assays Highlights the Importance of Sensitive Detection in Transplant Tolerance Chimerism, cell-free DNA and post-transplant monitoring Poster Interlaboratory Assessment of Virtual and Flow Cytometric Crossmatch Concordance HLA antibodies, crossmatching and epletsLab quality, accreditation and operations Poster A Global Proficiency Testing Resource for HLA Typing: The UCLA international B cell line exchange Lab quality, accreditation and operationsHLA typing, sequencing and genotyping |
University of British Columbia Vancouver, BC | |
Public research university with a faculty of medicine affiliated with teaching hospitals in Vancouver and across British Columbia. | Industry Tue Oct 27 12:30pm–1:25pm Redefining Histocompatibility: Faster HLA Typing, Deeper Ab Insights HLA typing, sequencing and genotypingHLA antibodies, crossmatching and eplets Talk Tue Oct 27 2:30pm–2:45pm A Novel Serum Lipid Signature Identifies Antibody-Mediated Rejection Without Biopsy Solid organ transplantationChimerism, cell-free DNA and post-transplant monitoring Session Wed Oct 28 10:30am–12:00pm Plenary 2: Real World Implications of Deploying AI in Transplantation Bioinformatics, AI and risk modeling Talk Wed Oct 28 2:45pm–3:15pm Pre-analytic Considerations and the Analytic Validity of Decentralized Donor-Derived Cell-Free DNA Testing Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Talk Thu Oct 29 10:00am–10:15am Talk Thu Oct 29 1:10pm–1:40pm "Classical" Antibody-Mediated Rejection (ABMR) with Detectable Donor-Specific HLA Antibodies Solid organ transplantationHLA antibodies, crossmatching and eplets Talk Thu Oct 29 2:25pm–2:40pm Impact of Pre-Analytic Sample Stability on Downstream Donor-Derived Cell Free DNA Results Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Session Thu Oct 29 4:15pm–5:45pm Workshop 5: Transplant Balancing Act: Navigating Infection and Rejection in the Era of the Microbiome Solid organ transplantation Session Fri Oct 30 9:30am–10:30am ASHI/CST Joint Session 5: cfDNA Diagnostics Utility in the Era of "Liquid Biopsy". Promises and Challenges in Transplantation Chimerism, cell-free DNA and post-transplant monitoringSolid organ transplantation Session Fri Oct 30 10:30am–12:00pm ASHI/CST Joint Session 6: Desensitization in Solid Organ Transplantation: From immunologic challenge to new opportunities Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Evaluation of Rbceq2 for High Resolution Genotyping of ABO And Other Relevant Blood Group Genes in Transplantation HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling |
Thermo Fisher Scientific Waltham, MA | |
Through its One Lambda line, makes HLA typing and antibody detection assays plus post-transplant monitoring tests for transplant labs and clinicians. | Booth Exhibiting at Booth 311 Mon, Oct 267:00pm–9:00pmTue, Oct 279:15am–10:15amWed, Oct 289:30am–10:30am, 4:15pm–4:45pmThu, Oct 299:30am–10:00am Industry Tue Oct 27 12:30pm–1:25pm Redefining Histocompatibility: Faster HLA Typing, Deeper Ab Insights HLA typing, sequencing and genotypingHLA antibodies, crossmatching and eplets Talk Tue Oct 27 3:00pm–3:15pm Cytoplasmic Tail Polymorphisms are Associated with the Pan-HLA-C Pattern in LABScreen(TM) Assays HLA antibodies, crossmatching and epletsHLA typing, sequencing and genotyping Industry Wed Oct 28 12:40pm–1:35pm Modernizing the HLA Laboratory through Platform Innovation Lab quality, accreditation and operations Poster Automation of LABType HLA Typing using the HLA PRO Liquid Handling Platform Lab quality, accreditation and operationsHLA typing, sequencing and genotyping Poster Experimental Modification of Non-Specific Reactivity Treatment to Reduce Unexpected Reactivity HLA antibodies, crossmatching and epletsLab quality, accreditation and operations Poster Widespread HC-10 Reactivity Across HLA Class I–Expressing Cell Types HLA antibodies, crossmatching and eplets Poster Novel Research Algorithm for Detecting Partial and Complete Loss of Human Leukocyte Antigen Chimerism, cell-free DNA and post-transplant monitoringBioinformatics, AI and risk modeling Poster From Manual to Automated: Performance analysis of the One Lambda™ HybriType™ HLA plus typing Flex Kit using the HLA PRO Lab quality, accreditation and operationsHLA typing, sequencing and genotyping Poster Evaluation of Informative Marker Performance: One Lambda™ Devyser Chimerism Plus vs Standard Assay for Donor-Recipient Analysis on the MiSeq™ i100 Plus Platform Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Poster HLA PRO Automated System Produces Reproducible, High-Quality Data using One Lambda™ HybriType™ HLA Plus Typing Flex Kit Lab quality, accreditation and operationsHLA typing, sequencing and genotyping Poster Magnetic Bead–Based Isolation Enables Kinetic Characterization of HLA-Specific Antibodies by SPR and BLI HLA antibodies, crossmatching and eplets Poster Using HDX-MS to Map the Epitope of Anti-HLA-B*08:01 Antibodies HLA antibodies, crossmatching and eplets Poster HLA PRO: Supporting high-throughput HLA antibody screening workflow Lab quality, accreditation and operationsHLA antibodies, crossmatching and eplets |
University of California, San Francisco San Francisco, CA | |
Public university devoted to health sciences, with schools of medicine, nursing, pharmacy and dentistry and a medical center with organ transplant programs. | Talk Mon Oct 26 3:00pm–3:40pm Engineering an Implantable Bioartificial Kidney: Integrating Device Development and Renal Cell Biology Solid organ transplantation Talk Tue Oct 27 3:00pm–3:15pm Clinical Genome Resource HLA Working Group: HLA Curation in Complex Diseases HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling Talk Wed Oct 28 3:15pm–3:30pm Mapping Immunogenic HLA Eplets Using Monospecific Antibodies in Transplant Patients to Improve Risk Stratification and Access HLA antibodies, crossmatching and eplets Poster Resolving HLA-DPB1 Typing Ambiguity in a Deceased Donor Using Long-Read Nanopore Sequencing HLA typing, sequencing and genotyping Poster Integrating SSHAARP Maps into the Allele Frequencies Net Database Bioinformatics, AI and risk modelingHLA typing, sequencing and genotyping |
Brigham and Women's Hospital Boston, MA | |
Teaching hospital of Harvard Medical School and member of the Mass General Brigham system, with organ and stem cell transplant programs. | Session Mon Oct 26 12:30pm–5:00pm Featured Topic: Organs and Tissues on Demand: Bioengineering and Regenerative Medicine in Transplantation Solid organ transplantation Talk Tue Oct 27 2:30pm–2:45pm A Reusable Novel-Allele Discovery Pipeline Closes ABO Allele-Database Gaps HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling Session Wed Oct 28 2:45pm–4:15pm Workshop 3: Integrating Apheresis, HLA Diagnostics and Clinical Management of the Sensitized Patient HLA antibodies, crossmatching and epletsSolid organ transplantation Talk Thu Oct 29 2:10pm–2:40pm Biopsy-proven ABMR in the Absence of Detectable HLA-DSA Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Antibody Against Epitope 76V+80N Causes Unexpected Positive Crossmatches: A case for listing HLA-c as unacceptable HLA antibodies, crossmatching and eplets Poster Peptide-Dependent Donor-Specific HLA Heterodimer Antibodies Independently Predict Adverse Transplant Outcomes HLA antibodies, crossmatching and eplets |
Find buyers in HLA typing, sequencing and genotyping
Tell us what you sell and we’ll find the people at organizations working on HLA typing, sequencing and genotyping most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ASHI 2026 by
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction